Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Return on Equity (2021 - 2025)

Historic Return on Equity for GeneDx Holdings (WGS) over the last 5 years, with Q3 2025 value amounting to 0.01%.

  • GeneDx Holdings' Return on Equity rose 4300.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 0.22% for FY2024, which is 5100.0% up from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Return on Equity is 0.01%, which was up 4300.0% from 0.01% recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Return on Equity peaked at 2.79% during Q3 2021, and registered a low of 1.83% during Q1 2023.
  • In the last 5 years, GeneDx Holdings' Return on Equity had a median value of 0.42% in 2024 and averaged 0.36%.
  • As far as peak fluctuations go, GeneDx Holdings' Return on Equity crashed by -32600bps in 2022, and later soared by 12500bps in 2024.
  • Quarter analysis of 5 years shows GeneDx Holdings' Return on Equity stood at 0.63% in 2021, then plummeted by -114bps to 1.35% in 2022, then soared by 46bps to 0.73% in 2023, then soared by 68bps to 0.23% in 2024, then surged by 103bps to 0.01% in 2025.
  • Its Return on Equity stands at 0.01% for Q3 2025, versus 0.01% for Q2 2025 and 0.15% for Q1 2025.